全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
化学进展  2013 

草酸钙结石患者尿液中纳米微晶的成核、生长、聚集及其与结石形成的关系

DOI: 10.7536/PC121129, PP. 642-649

Keywords: 生物矿化,草酸钙,纳米晶体,肾结石

Full-Text   Cite this paper   Add to My Lib

Abstract:

肾结石的主要组分是草酸钙(CaOxa)等晶体。目前肾结石只能在形成以后才能被诊断,这给患者带来了极大的痛苦。肾结石的形成与尿液中的纳米微晶性质密切相关,如果能在结石形成之前或形成初期早期检测,则可以有效地预防肾结石发生发展。本文结合本课题组的工作,从微晶尺寸、微晶的聚集程度、形貌、化学组分、Zeta电位和稳定性等方面综述了肾结石患者尿液中纳米微晶的性质差异及其与肾结石形成的关系,并与健康对照者进行了比较;讨论了CaOxa结石患者在服用防石药物柠檬酸钾后尿微晶的性质变化。研究结果表明尿液中的纳米微晶的聚集是导致微晶快速增大和结石形成的关键因素,说明通过调控纳米微晶的物理、化学性质,有可能抑制肾结石的形成和复发。

References

[1]  Ding Y M, Xia Z Y, Zhang G N, Ouyang J M. Adv. Mater. Res., 2012, 554/556: 47-50
[2]  Duan C Y, Zhang G N, Ding Y M, Gui B S, Xue J F, Ouyang J M. Int. J. Nanomed., 2013, 8: 909-918
[3]  Knauf F, Preisig P A. Kidney Int., 2011, 80(4): 327-329
[4]  Peng H, Ouyang J M, Yao X Q, Yang R E. Int. J. Nanomed., 2012, 7(8): 4727-4737
[5]  Robertson W G, Peacock M, Marshall R W, Marshall D H, Nordin B E. New Engl. J. Med., 1976, 294(5): 249-252
[6]  Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Kidney Int., 2005, 67: 1934-1943
[7]  Daudon M, Jungers P. Nephron Physiol., 2004, 98: 31-36
[8]  Robert M, Boularan A M, Delbos O, Guiter J, Descomps B. Urol. Int., 1998, 60: 41-46
[9]  Li J J, Hou S H, Xia Z Y, Ouyang J M. Spectrosc. Spect. Anal., 2011, 31(8): 2263-2267
[10]  Mullin J W. Crystallization, 3rd ed. London: Butterworth Heinemann, 2000. 102-288
[11]  Michelacci Y M, Glashan R Q, Schor N. Kidney Int., 1989, 36: 1022-1028
[12]  Schwille P O, Schmiedl A, Herrmann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J. Urol. Res., 1999, 27: 117-126
[13]  Daudon M, Cohen-Solal F, Barbey F, Gagnadoux M, Knebelmann B, Jungers P. Urol. Res., 2003, 31: 207-211
[14]  Wesson A J, Worcester M E, Wiessner J H, Mandel N S. Kidney Int., 1998, 53: 952-957
[15]  Mandel N. J. Am. Soc. Nephrol. 1994, 5 (Suppl. 1): S37-S45
[16]  Murphy D L, Beretvas S N, Pituch K A. Structural Equation Modeing: A Multidisciplinary Journal, 2011, 18(3): 430-448
[17]  Fuselier H A, Ward D M. Urology, 1995, 45: 942-946
[18]  李君君 (Li J J), 侯善华 (Hou S H), 夏志月 (Xia Z Y), 欧阳健明 (Ouyang J M). 无机化学学报 (J. Inorg. Chem.), 2012, 28(2): 245-250
[19]  晋勇 (Jin Y), 孙小松 (Sun X S), 薛屺 (Xue J). X-射线衍射分析技术 (X-ray Diffraction Analysis Techniques). 北京: 国防工业出版社 (Beijing: National Defence Industrial Press), 2008. 173-174, 193
[20]  Lee T, Lin Y C. Cryst. Growth Des., 2011, 11(7): 2973-2992
[21]  An Z, Lee S, Oppenheimer H, Wesson J A, Ward M D. J. Am. Chem. Soc., 2010, 132(38): 13188-13190
[22]  He J Y, Deng S P, Ouyang J M. IEEE Trans. Nanobiosci., 2010, 9(2): 156-163
[23]  Verdesca S, Fogazzi G B, Garigali G, Messa P, Daudon M. Clin. Chem. Lab. Med., 2011, 49(3): 515-520
[24]  Robert M, Boularan A M, Delbos O, Monnier L, Grasset D. Eur. Urol., 1996, 29(4): 456-461
[25]  Elliot J S, Rabinowitz I N. J. Urol., 1980, 123(3): 324-327
[26]  Werness P G, Bergert J H, Smith L H. J. Cryst Growth, 1981, 53: 166-181
[27]  Herrmann U, Schwille P O. Urol. Res., 1992, 20(2): 157-64
[28]  Gui B S, Huang Z J, Xu X J, Li M R, He J Y, Ouyang J M. J. Nanosci. Nanotechnol., 2010, 10(8): 5232-5241
[29]  Deng F, Ouyang J M. Mat. Sci. Eng. C-Bio. S, 2006, 26(4): 688-691
[30]  He J Y, Ouyang J M, Yang Y E. Mater. Sci. Eng. C-Bio S, 2010, 30: 878-885
[31]  Qiu S R, Wierzbicki A, Salter E A, Zepeda S, Orme C A, Hoyer J R, Nancollas G H, Cody A M, de Yoreo J J. J. Am. Chem. Soc., 2005, 127: 9036-9044
[32]  Saw N K, Rao P N, Kavanagh J P. Urol. Res., 2008, 36: 11-15
[33]  Baumann J M, Affolter B, Meyer R. Urol. Res., 2010, 38(1): 21-27
[34]  Vervaet B A, Verhulst A, Dauwe S E, de Broe M E, D'Haese P C. Kidney Int., 2009, 75(1): 41-51
[35]  Frisken B. Appl. Opt., 2001, 40(24): 4087-4091

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133